Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Holographic imaging and deep learning diagnose malaria

    Author:
    HT Staff
    Publish date: October 13, 2016

    Image by Peter H.

    • Read More

    News

    Cord blood product granted breakthrough designation

    Author:
    HT Staff
    Publish date: October 12, 2016

    Photo courtesy of NHS The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for NiCord®, a product in...

    • Read More

    News

    Bovine heparin may be comparable to porcine heparin

    Author:
    HT Staff
    Publish date: October 12, 2016

    A new study suggests that heparin derived from cattle may be as effective as heparin derived from pigs, but more research is needed....

    • Read More

    News

    FDA says ROCKET AF trial results hold up

    Author:
    HT Staff
    Publish date: October 12, 2016

    The US Food and Drug Administration (FDA) has concluded that results of the ROCKET AF trial were not significantly affected by accuracy issues...

    • Read More

    News

    Plasmapheresis system cleared by FDA

    Author:
    HT Staff
    Publish date: October 12, 2016

    Photo from Business Wire The US Food and Drug Administration (FDA) has granted 510(k) clearance for the Aurora™ Xi Plasmapheresis System. The...

    • Read More

    News

    FDA grants priority review for MM drug

    Author:
    HT Staff
    Publish date: October 10, 2016

    Photo courtesy of Janssen The US Food and Drug Administration (FDA) has granted priority review for part of a supplemental biologics license...

    • Read More

    News

    FDA clears use of coagulation analyzer

    Author:
    HT Staff
    Publish date: October 9, 2016

    The US Food and Drug Administration (FDA) has granted 510(k) clearance for the Xprecia Stride Coagulation Analyzer from Siemens Healthcare...

    • Read More

    News

    Immunotherapy produces CRs in kids with rel/ref ALL

    Author:
    HT Staff
    Publish date: October 7, 2016

    Of the patients who received the recommended dosage of blinatumomab, 39% achieved a CR within the first 2 treatment cycles. And 52% of these...

    • Read More

    News

    Study shows more bleeding with rivaroxaban than dabigatran

    Author:
    HT Staff
    Publish date: October 7, 2016

    A large, retrospective study comparing first-time users of rivaroxaban and dabigatran suggests that rivaroxaban poses a higher risk of bleeding in...

    • Read More

    News

    Triplet improves PFS in relapsed/refractory MM

    Author:
    HT Staff
    Publish date: October 7, 2016

    Results of the phase 3 POLLUX trial suggest that adding daratumumab to treatment with lenalidomide and dexamethasone can improve progression-free...

    • Read More

    News

    Drug granted conditional approval to treat CLL in Canada

    Author:
    HT Staff
    Publish date: October 6, 2016

    of venetoclax (Venclexta) Photo courtesy of AbbVie Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for the BCL-2...

    • Read More

    News

    Findings may aid drug delivery, bioimaging

    Author:
    HT Staff
    Publish date: October 6, 2016

    to illuminate microfluidic device simulating a blood vessel. Photo from Anson Ma/UConn A study published in Biophysical Journal has revealed new...

    • Read More

    News

    Vitamin D affects HSPC production, team says

    Author:
    HT Staff
    Publish date: October 5, 2016

    Photo by Ian Johnston The availability of vitamin D during embryonic development can affect hematopoietic stem and progenitor cells (HSPCs),...

    • Read More

    News

    Lifestyle may impact life expectancy in mild SCD

    Author:
    HT Staff
    Publish date: October 5, 2016

    alongside a normal one Image by Betty Pace A case series published in Blood indicates that some patients with mildly symptomatic sickle cell...

    • Read More

    News

    Inflammation may predict transformation to AML

    Author:
    HT Staff
    Publish date: October 5, 2016

    Inflammatory signaling in mesenchymal niche cells can be used to predict the transformation from pre-leukemic syndrome to acute myeloid leukemia (...

    • Read More

    Pages

    • « first
    • …
    • 92
    • 93
    • 94
    • 95
    • 96
    • 97
    • 98
    • 99
    • 100
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery